DK131033C - - Google Patents

Info

Publication number
DK131033C
DK131033C DK247673A DK247673A DK131033C DK 131033 C DK131033 C DK 131033C DK 247673 A DK247673 A DK 247673A DK 247673 A DK247673 A DK 247673A DK 131033 C DK131033 C DK 131033C
Authority
DK
Denmark
Application number
DK247673A
Other languages
Danish (da)
Other versions
DK131033B (da
Inventor
M Carissimi
F Ravenna
Original Assignee
Maggioni & C Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni & C Spa filed Critical Maggioni & C Spa
Publication of DK131033B publication Critical patent/DK131033B/da
Application granted granted Critical
Publication of DK131033C publication Critical patent/DK131033C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK247673AA 1972-05-05 1973-05-04 Analogifremgangsmåde til fremstilling af kaliumsalte af 2-phenyl-6-sulfamyl-7-chlor-1,2,3,4-tetrahydro-4-quinazolinon. DK131033B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2392572 1972-05-05

Publications (2)

Publication Number Publication Date
DK131033B DK131033B (da) 1975-05-20
DK131033C true DK131033C (en:Method) 1975-10-06

Family

ID=11210914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK247673AA DK131033B (da) 1972-05-05 1973-05-04 Analogifremgangsmåde til fremstilling af kaliumsalte af 2-phenyl-6-sulfamyl-7-chlor-1,2,3,4-tetrahydro-4-quinazolinon.

Country Status (12)

Country Link
US (1) US3870720A (en:Method)
JP (1) JPS49132221A (en:Method)
AU (1) AU469087B2 (en:Method)
BE (1) BE799087A (en:Method)
CA (1) CA982578A (en:Method)
DE (1) DE2322699C2 (en:Method)
DK (1) DK131033B (en:Method)
FR (1) FR2183806B1 (en:Method)
GB (1) GB1413008A (en:Method)
NL (1) NL7306164A (en:Method)
SE (1) SE400768B (en:Method)
ZA (1) ZA732937B (en:Method)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2952680A (en) * 1960-09-13 Derivatives of x-quevazolone
US987847A (en) * 1910-04-12 1911-03-28 Rubin W Weeks Harness.
US3440244A (en) * 1958-02-17 1969-04-22 Pfizer & Co C 3,6-disubstituted-7-sulfamyl-1,2,4-benzthiazide-1,1-dioxides
US3072656A (en) * 1960-01-22 1963-01-08 Ciba Geigy Corp 2-cycloaliphatic-6-sulfamyl-7-halo(or trihalomethyl)-1, 2, 3, 4-tetrahydro-4-quinazolones
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones

Also Published As

Publication number Publication date
SE400768B (sv) 1978-04-10
US3870720A (en) 1975-03-11
NL7306164A (en:Method) 1973-11-07
FR2183806A1 (en:Method) 1973-12-21
GB1413008A (en) 1975-11-05
DE2322699A1 (de) 1974-01-10
ZA732937B (en) 1974-03-27
FR2183806B1 (en:Method) 1976-05-14
DK131033B (da) 1975-05-20
DE2322699C2 (de) 1983-10-27
AU5516173A (en) 1974-11-07
BE799087A (fr) 1973-08-31
JPS49132221A (en:Method) 1974-12-18
CA982578A (en) 1976-01-27
AU469087B2 (en) 1976-02-05

Similar Documents

Publication Publication Date Title
JPS49132221A (en:Method)
AU474296B2 (en:Method)
CH571133A5 (en:Method)
CH566456A5 (en:Method)
CH560589A5 (en:Method)
CH561791A5 (en:Method)
CH562354A5 (en:Method)
CH562542A5 (en:Method)
CH562791A5 (en:Method)
CH562973A5 (en:Method)
CH566101A5 (en:Method)
CH571616A5 (en:Method)
CH571281A5 (en:Method)
CH566490A5 (en:Method)
CH566543A5 (en:Method)
CH566589A5 (en:Method)
CH567390A5 (en:Method)
CH567875A5 (en:Method)
CH568713A5 (en:Method)
CH568940A5 (en:Method)
CH569930A5 (en:Method)
CH571012A5 (en:Method)
CH571124A5 (en:Method)
CH1088672A4 (en:Method)
CH560088A5 (en:Method)

Legal Events

Date Code Title Description
PBP Patent lapsed